The KOSPI Rout Has Reached Korea’s Central Bank
When Governor Shin said Thursday the selloff is weighing on consumption, the derating crossed from portfolios into monetary policy.
Hermès Missed. Now Investors Must Ask What They Were Paying For.
China hit accessories, and the luxury stock that held a premium suddenly looks more cyclical.
Big Gains on Tap as Sub-US$1 Silver-Gold Discovery Takes Shape
A note from our friends at Resource Stock Digest(ad) Silver and gold are obliterating all previous profit records with next-level…
Eaton Owns the Bottleneck Stalling AI Data Centers
Switchgear lead times past 100 weeks keep Eaton’s backlog sticky.
Jio Platforms Is Subscribed 2.36x. What That Tells Long-Term Investors.
The real question isn’t the IPO. It’s whether your India and Reliance exposure is priced for what comes next.
The world could quit tobacco. It cannot quit controlling pests.
A note from our friends at Med-X Inc(ad) National Investor Network Special Situation Letter A Private Message for Independent Investors…
GSK’s Jemperli Just Got a First-and-Only Label. Is the Stock Finally Worth Buying?
A surgery-sparing FDA approval gives GSK its most compelling oncology story in years, but the stock’s discount to peers tells a complicated tale.
Elon Musk’s Next Partnership: Buy This Stock Now
October 20, 2026 Bonus Content: If Iran’s Hormuz Deal Works, Brent Falls Hard. Here’s Who Gets Hurt First. A note…
Trump Waived the Russia Tariffs He Signed. What It Means for Oil and Defence Shares.
Putin wants a summit without Zelensky, Trump is pausing his own Russia law, and the uncertainty is moving Brent and defence stocks.
Chubb Reports Tonight With Profit Expected Down 17%
CB is up about 5% in a week heading into Tuesday’s release, leaving little cushion if catastrophe losses or the accident-year ratio disappoint.